GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Windlas Biotech Ltd

Windlas Biotech: Ashok Kumar Windlass resigns as Whole-time Director

MANAGEMENT ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 05 Nov 2026, 05:18 PM IST  ·  BSE ID: 39dd03a4-47f7-4a02-a085-119ac5b87567
View Original BSE Filing (PDF)
💡
In Simple Terms
A long-time director at Windlas Biotech has stepped down as part of the company's future leadership plan.
🤖 AI Summary
  • Mr. Ashok Kumar Windlass resigned as Whole-time Director and Director of Windlas Biotech.
  • The resignation is effective November 5, 2026, at 10:00 A.M.
  • The resignation is attributed to the company's long-term succession planning.
  • Mr. Windlass will also cease to be a Member of the Corporate Social Responsibility Committee.
🏢 How This Affects the Company
⚙️
Operational Impact
The departure of a Whole-time Director signifies a shift in the company's senior leadership structure.
⚠️
Risk Impact
Management changes can introduce uncertainty regarding strategic direction and operational continuity.
👥 What This Means For Shareholders
✅
Action Required
No immediate action is required from shareholders regarding this management change.
👤
Who Is Affected
All shareholders are affected by changes in the company's board composition and senior management.
🔍
Management Signal
The resignation indicates a proactive approach by the company to implement its long-term succession strategy.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Announcement of new Whole-time Director appointment.
Subsequent board meeting outcomes for committee changes.
Updates on leadership transition and strategic continuity.
MEDIUM RISK Resignation of a key Whole-time Director can impact strategic execution and market perception.
💡 Investor Takeaway
Mr. Ashok Kumar Windlass has resigned as Whole-time Director and Director of Windlas Biotech, effective November 5, 2026, citing succession planning.
❓ Frequently Asked Questions
Who has resigned from Windlas Biotech?
Mr. Ashok Kumar Windlass has resigned from the position of Whole-time Director and Director of Windlas Biotech.
When is Mr. Ashok Kumar Windlass's resignation effective?
The resignation is effective November 5, 2026, at 10:00 A.M.
What is the reason for Mr. Ashok Kumar Windlass's resignation?
The resignation is due to the company's long-term succession planning.
Will Mr. Ashok Kumar Windlass continue on any board committees?
No, he will cease to be a Member of the Corporate Social Responsibility Committee of the Company.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.